サマリー

抗菌薬の世界市場 2023-2027
抗菌薬市場は2022-2027年に9億9,081万米ドル成長し、予測期間中のCAGRは4.21%で加速すると予測されます。この調査レポートは、抗菌薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、細菌感染症の有病率の増加、細菌に起因する様々な疾患とその治療に対する意識の高まり、世界的な高齢化率の上昇が牽引しています。
Technavio社の抗菌薬市場は以下のように分類されます：
投与経路別
- 静脈注射
- 経口
- その他
薬剤クラス別
- B-ラクタム
- キノロン系
- マクロライド系
- テトラサイクリン系
- その他
地域別
- アジア
- 北米
- ヨーロッパ
- その他の地域（ROW）
本調査では、抗菌薬へのナノテクノロジーの応用が、今後数年間の抗菌薬市場の成長を促進する主要な理由の1つであると特定している。また、年齢に応じた抗生物質の研究開発に対する優先順位の上昇や、提携・協力関係の増加が、市場の大きな需要につながるとしている。
本レポートでは、抗菌薬市場について以下の領域をカバーしています：
- 抗菌薬市場のサイジング
- 抗菌薬市場予測
- 抗菌薬市場産業分析
本レポートでは、抗菌薬市場の主要ベンダー（AbbVie Inc.、Basilea Pharmaceutica Ltd.、Bayer AG、Binnopharm Group LLC、Bristol Myers Squibb Co.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Kyorin Pharmaceutical Co.Ltd.、Lupin Ltd.、Merck KGaA、Novartis AG、Paratek Pharmaceuticals Inc.、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Cipla Ltd.、Melinta Therapeutics LLC、Shionogi and Co.Ltd.などである。また、抗菌薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/antibacterial-drugs-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global antibacterial drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global antibacterial drugs market 2017 - 2021 ($ million)
o 4.2 Route of administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
o 4.3 Drug class Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Drug class Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Intravenous - Market size and forecast 2022-2027
o Exhibit 34: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
o 6.4 Oral - Market size and forecast 2022-2027
o Exhibit 38: Chart on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Oral - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Oral - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Route of Administration
o Exhibit 46: Market opportunity by Route of Administration ($ million)
o Exhibit 47: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Drug Class
o 7.1 Market segments
o Exhibit 48: Chart on Drug Class - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Drug Class - Market share 2022-2027 (%)
o 7.2 Comparison by Drug Class
o Exhibit 50: Chart on Comparison by Drug Class
o Exhibit 51: Data Table on Comparison by Drug Class
o 7.3 B-lactam - Market size and forecast 2022-2027
o Exhibit 52: Chart on B-lactam - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on B-lactam - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on B-lactam - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on B-lactam - Year-over-year growth 2022-2027 (%)
o 7.4 Quinolones - Market size and forecast 2022-2027
o Exhibit 56: Chart on Quinolones - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Quinolones - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Quinolones - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Quinolones - Year-over-year growth 2022-2027 (%)
o 7.5 Macrolids - Market size and forecast 2022-2027
o Exhibit 60: Chart on Macrolids - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Macrolids - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Macrolids - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Macrolids - Year-over-year growth 2022-2027 (%)
o 7.6 Tetracyclins - Market size and forecast 2022-2027
o Exhibit 64: Chart on Tetracyclins - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Tetracyclins - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Tetracyclins - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Tetracyclins - Year-over-year growth 2022-2027 (%)
o 7.7 Others - Market size and forecast 2022-2027
o Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Drug Class
o Exhibit 72: Market opportunity by Drug Class ($ million)
o Exhibit 73: Data Table on Market opportunity by Drug Class ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share by geography 2022-2027 (%)
o Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.4 North America - Market size and forecast 2022-2027
o Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 111: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 115: Market opportunity by geography ($ million)
o Exhibit 116: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 123: AbbVie Inc. - Overview
o Exhibit 124: AbbVie Inc. - Product / Service
o Exhibit 125: AbbVie Inc. - Key news
o Exhibit 126: AbbVie Inc. - Key offerings
o 12.4 Bayer AG
o Exhibit 127: Bayer AG - Overview
o Exhibit 128: Bayer AG - Business segments
o Exhibit 129: Bayer AG - Key news
o Exhibit 130: Bayer AG - Key offerings
o Exhibit 131: Bayer AG - Segment focus
o 12.5 Bristol Myers Squibb Co.
o Exhibit 132: Bristol Myers Squibb Co. - Overview
o Exhibit 133: Bristol Myers Squibb Co. - Product / Service
o Exhibit 134: Bristol Myers Squibb Co. - Key news
o Exhibit 135: Bristol Myers Squibb Co. - Key offerings
o 12.6 Cipla Ltd.
o Exhibit 136: Cipla Ltd. - Overview
o Exhibit 137: Cipla Ltd. - Business segments
o Exhibit 138: Cipla Ltd. - Key news
o Exhibit 139: Cipla Ltd. - Key offerings
o Exhibit 140: Cipla Ltd. - Segment focus
o 12.7 Eli Lilly and Co.
o Exhibit 141: Eli Lilly and Co. - Overview
o Exhibit 142: Eli Lilly and Co. - Product / Service
o Exhibit 143: Eli Lilly and Co. - Key news
o Exhibit 144: Eli Lilly and Co. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 150: GlaxoSmithKline Plc - Overview
o Exhibit 151: GlaxoSmithKline Plc - Business segments
o Exhibit 152: GlaxoSmithKline Plc - Key news
o Exhibit 153: GlaxoSmithKline Plc - Key offerings
o Exhibit 154: GlaxoSmithKline Plc - Segment focus
o 12.10 Kyorin Pharmaceutical Co. Ltd.
o Exhibit 155: Kyorin Pharmaceutical Co. Ltd. - Overview
o Exhibit 156: Kyorin Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 157: Kyorin Pharmaceutical Co. Ltd. - Key offerings
o 12.11 Lupin Ltd.
o Exhibit 158: Lupin Ltd. - Overview
o Exhibit 159: Lupin Ltd. - Product / Service
o Exhibit 160: Lupin Ltd. - Key news
o Exhibit 161: Lupin Ltd. - Key offerings
o 12.12 Merck KGaA
o Exhibit 162: Merck KGaA - Overview
o Exhibit 163: Merck KGaA - Business segments
o Exhibit 164: Merck KGaA - Key news
o Exhibit 165: Merck KGaA - Key offerings
o Exhibit 166: Merck KGaA - Segment focus
o 12.13 Novartis AG
o Exhibit 167: Novartis AG - Overview
o Exhibit 168: Novartis AG - Business segments
o Exhibit 169: Novartis AG - Key offerings
o Exhibit 170: Novartis AG - Segment focus
o 12.14 Paratek Pharmaceuticals Inc.
o Exhibit 171: Paratek Pharmaceuticals Inc. - Overview
o Exhibit 172: Paratek Pharmaceuticals Inc. - Product / Service
o Exhibit 173: Paratek Pharmaceuticals Inc. - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 174: Pfizer Inc. - Overview
o Exhibit 175: Pfizer Inc. - Product / Service
o Exhibit 176: Pfizer Inc. - Key news
o Exhibit 177: Pfizer Inc. - Key offerings
o 12.16 Sanofi
o Exhibit 178: Sanofi - Overview
o Exhibit 179: Sanofi - Business segments
o Exhibit 180: Sanofi - Key news
o Exhibit 181: Sanofi - Key offerings
o Exhibit 182: Sanofi - Segment focus
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 183: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 184: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 185: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 186: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 187: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 188: Inclusions checklist
o Exhibit 189: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 190: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 191: Research methodology
o Exhibit 192: Validation techniques employed for market sizing
o Exhibit 193: Information sources
o 13.5 List of abbreviations
o Exhibit 194: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global antibacterial drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Drug class Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Route of Administration ($ million)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits48: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits49: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Drug Class
Exhibits51: Data Table on Comparison by Drug Class
Exhibits52: Chart on B-lactam - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on B-lactam - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on B-lactam - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on B-lactam - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Quinolones - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Quinolones - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Quinolones - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Quinolones - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Macrolids - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Macrolids - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Macrolids - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Macrolids - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Tetracyclins - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Tetracyclins - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Tetracyclins - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Tetracyclins - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Drug Class ($ million)
Exhibits73: Data Table on Market opportunity by Drug Class ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share by geography 2022-2027 (%)
Exhibits76: Data Table on Market share by geography 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity by geography ($ million)
Exhibits116: Data Tables on Market opportunity by geography ($ million)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: AbbVie Inc. - Overview
Exhibits124: AbbVie Inc. - Product / Service
Exhibits125: AbbVie Inc. - Key news
Exhibits126: AbbVie Inc. - Key offerings
Exhibits127: Bayer AG - Overview
Exhibits128: Bayer AG - Business segments
Exhibits129: Bayer AG - Key news
Exhibits130: Bayer AG - Key offerings
Exhibits131: Bayer AG - Segment focus
Exhibits132: Bristol Myers Squibb Co. - Overview
Exhibits133: Bristol Myers Squibb Co. - Product / Service
Exhibits134: Bristol Myers Squibb Co. - Key news
Exhibits135: Bristol Myers Squibb Co. - Key offerings
Exhibits136: Cipla Ltd. - Overview
Exhibits137: Cipla Ltd. - Business segments
Exhibits138: Cipla Ltd. - Key news
Exhibits139: Cipla Ltd. - Key offerings
Exhibits140: Cipla Ltd. - Segment focus
Exhibits141: Eli Lilly and Co. - Overview
Exhibits142: Eli Lilly and Co. - Product / Service
Exhibits143: Eli Lilly and Co. - Key news
Exhibits144: Eli Lilly and Co. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Overview
Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits147: F. Hoffmann La Roche Ltd. - Key news
Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits150: GlaxoSmithKline Plc - Overview
Exhibits151: GlaxoSmithKline Plc - Business segments
Exhibits152: GlaxoSmithKline Plc - Key news
Exhibits153: GlaxoSmithKline Plc - Key offerings
Exhibits154: GlaxoSmithKline Plc - Segment focus
Exhibits155: Kyorin Pharmaceutical Co. Ltd. - Overview
Exhibits156: Kyorin Pharmaceutical Co. Ltd. - Product / Service
Exhibits157: Kyorin Pharmaceutical Co. Ltd. - Key offerings
Exhibits158: Lupin Ltd. - Overview
Exhibits159: Lupin Ltd. - Product / Service
Exhibits160: Lupin Ltd. - Key news
Exhibits161: Lupin Ltd. - Key offerings
Exhibits162: Merck KGaA - Overview
Exhibits163: Merck KGaA - Business segments
Exhibits164: Merck KGaA - Key news
Exhibits165: Merck KGaA - Key offerings
Exhibits166: Merck KGaA - Segment focus
Exhibits167: Novartis AG - Overview
Exhibits168: Novartis AG - Business segments
Exhibits169: Novartis AG - Key offerings
Exhibits170: Novartis AG - Segment focus
Exhibits171: Paratek Pharmaceuticals Inc. - Overview
Exhibits172: Paratek Pharmaceuticals Inc. - Product / Service
Exhibits173: Paratek Pharmaceuticals Inc. - Key offerings
Exhibits174: Pfizer Inc. - Overview
Exhibits175: Pfizer Inc. - Product / Service
Exhibits176: Pfizer Inc. - Key news
Exhibits177: Pfizer Inc. - Key offerings
Exhibits178: Sanofi - Overview
Exhibits179: Sanofi - Business segments
Exhibits180: Sanofi - Key news
Exhibits181: Sanofi - Key offerings
Exhibits182: Sanofi - Segment focus
Exhibits183: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits184: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits185: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits186: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits187: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits188: Inclusions checklist
Exhibits189: Exclusions checklist
Exhibits190: Currency conversion rates for US$
Exhibits191: Research methodology
Exhibits192: Validation techniques employed for market sizing
Exhibits193: Information sources
Exhibits194: List of abbreviations